INmune Bio, Inc. (INMB) ownership: Top institutional holder: VANGUARD GROUP INC ($1.49M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| VANGUARD GROUP INC | 957846.00 | $1.49M | 2025-12-31 |
| BlackRock, Inc. | 1194112.00 | $1.35M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 687015.00 | $776327.00 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 494969.00 | $559464.00 | 2026-03-31 |
| STATE STREET CORP | 290879.00 | $328693.00 | 2026-03-31 |
| AQR CAPITAL MANAGEMENT LLC | 270317.00 | $305458.00 | 2026-03-31 |
| UBS Group AG | 253340.00 | $286274.00 | 2026-03-31 |
| GOLDMAN SACHS GROUP INC | 231586.00 | $261692.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-07-02 | |
| Sell | null | 2026-07-02 | |
| Sell | null | 2026-07-02 | |
| Sell | null | 2026-07-02 | |
| Sell | null | 2026-07-02 | |
| Sell | null | 2026-07-02 | |
| Sell | null | 2025-12-01 | |
| Sell | null | 2025-12-01 |
Back to INMB overview · INMB earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.